Consolidating Statements of Cash Flows (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income	$ 757,201	$ 641,237	$ 573,395
Changes in operating assets and liabilities and non cash items included in net income	1,016,140	459,611	606,651
Net cash provided by operating activities	1,773,341	1,100,848	1,180,046
Cash flows from investing activities:
Additions of property and equipment, net	(617,597)	(550,146)	(400,156)
Acquisitions	(310,394)	(4,294,077)	(1,077,442)
Proceeds from asset sales	62,258	3,559	75,183
Proceeds from investment sales and other items	(11,149)	8,214	3,187
Net cash provided by (used in) by investing activities	(876,882)	(4,832,450)	(1,399,228)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(438,007)	3,904,893	127,660
Other items	(44,984)	(32,509)	(374,843)
Net cash provided by (used in) financing activities	(482,991)	3,872,384	(247,183)
Effect of exchange rate changes on cash	(967)	(786)
Net (decrease) increase in cash and cash equivalents	412,501	139,996	(466,365)
Cash and cash equivalents at beginning of the year	533,748	393,752	860,117
Cash and cash equivalents at end of the year	946,249	533,748	393,752
DaVita HealthCare Partners Inc.
Cash flows from operating activities:
Net income	633,446	536,017	478,001
Changes in operating assets and liabilities and non cash items included in net income	(443,071)	(383,619)	(230,599)
Net cash provided by operating activities	190,375	152,398	247,402
Cash flows from investing activities:
Additions of property and equipment, net	(55,252)	(72,125)	(52,653)
Acquisitions		(3,645,760)
Proceeds from asset sales	60,650
Proceeds from investment sales and other items	(4,944)	2,841	(6,077)
Net cash provided by (used in) by investing activities	454	(3,715,044)	(58,730)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(421,739)	3,909,760	113,762
Intercompany borrowing	585,441	(586,050)	(502,763)
Other items	52,620	68,697	(291,198)
Net cash provided by (used in) financing activities	216,322	3,392,407	(680,199)
Net (decrease) increase in cash and cash equivalents	407,151	(170,239)	(491,527)
Cash and cash equivalents at beginning of the year	195,037	365,276	856,803
Cash and cash equivalents at end of the year	602,188	195,037	365,276
Guarantor Subsidiaries
Cash flows from operating activities:
Net income	522,778	487,077	416,058
Changes in operating assets and liabilities and non cash items included in net income	652,374	15,693	287,537
Net cash provided by operating activities	1,175,152	502,770	703,595
Cash flows from investing activities:
Additions of property and equipment, net	(337,042)	(305,885)	(232,540)
Acquisitions	(156,830)	(564,499)	(1,048,136)
Proceeds from asset sales	1,608	3,559	75,183
Proceeds from investment sales and other items	(3,502)	(1,761)	9,264
Net cash provided by (used in) by investing activities	(495,766)	(868,586)	(1,196,229)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(11,061)	(23,805)	(1,896)
Intercompany borrowing	(664,154)	580,825	498,532
Other items	4,726	(25,097)	(4,002)
Net cash provided by (used in) financing activities	(670,489)	531,923	492,634
Net (decrease) increase in cash and cash equivalents	8,897	166,107
Cash and cash equivalents at beginning of the year	166,107
Cash and cash equivalents at end of the year	175,004	166,107
Non-Guarantor Subsidiaries
Cash flows from operating activities:
Net income	397,259	323,195	255,360
Changes in operating assets and liabilities and non cash items included in net income	10,555	122,485	(26,311)
Net cash provided by operating activities	407,814	445,680	229,049
Cash flows from investing activities:
Additions of property and equipment, net	(225,303)	(172,136)	(114,963)
Acquisitions	(153,564)	(83,818)	(29,306)
Proceeds from investment sales and other items	(2,703)	7,134
Net cash provided by (used in) by investing activities	(381,570)	(248,820)	(144,269)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(5,207)	18,938	15,794
Intercompany borrowing	78,713	5,225	4,231
Other items	(102,330)	(76,109)	(79,643)
Net cash provided by (used in) financing activities	(28,824)	(51,946)	(59,618)
Effect of exchange rate changes on cash	(967)	(786)
Net (decrease) increase in cash and cash equivalents	(3,547)	144,128	25,162
Cash and cash equivalents at beginning of the year	172,604	28,476	3,314
Cash and cash equivalents at end of the year	169,057	172,604	28,476
Consolidating Adjustments
Cash flows from operating activities:
Net income	(796,282)	(705,052)	(576,024)
Changes in operating assets and liabilities and non cash items included in net income	$ 796,282	$ 705,052	$ 576,024